Breaking News: TMO – Market Insights, Analysis & Latest Updates

TMO

Earnings call: Thermo Fisher raises EPS guidance amid steady growth

Thermo Fisher reported strong Q3 earnings, raising EPS guidance to $21.35-$22.07, while maintaining revenue outlook between $42.4-$43.3 billion despite reduced COVID-19 revenue.

investing.com • 23/10/2024 - 17:30 PM

TMO

Thermo Fisher raises profit forecast on strong demand for its tools and services

Thermo Fisher Scientific raises its profit forecast, driven by improved demand for drug development tools, despite missed revenue expectations in Q3.

investing.com • 23/10/2024 - 10:59 AM

TMO

Thermo Fisher Scientific Q3 earnings beat, revenue misses

Thermo Fisher Scientific's Q3 earnings beat expectations, but revenue fell slightly short. The company raised EPS guidance and launched new products despite a dip in stock.

investing.com • 23/10/2024 - 10:16 AM

TMO

Thermo Fisher Scientific earnings beat by $0.03, revenue fell short of estimates

Thermo Fisher Scientific's Q3 EPS was $5.28, beating estimates. FY 2024 guidance includes EPS of $21.35-$22.07. Stock down 3.42% in three months, up 27.96% yearly.

investing.com • 23/10/2024 - 10:03 AM

TMO

Thermo Fisher plant making infant RSV drug breached FDA rules - Reuters

Thermo Fisher's Greenville facility faced FDA inspection issues regarding contamination in Beyfortus manufacturing, but measures were reportedly taken to resolve them without evidence of patient harm.

investing.com • 04/10/2024 - 11:45 AM

TMO

Thermo Fisher's plant making infant RSV drug breached FDA rules, documents show

Thermo Fisher's Greenville facility repeatedly breached FDA drug safety rules, raising concerns over manufacturing practices despite resolving recent issues without evidence of harming patients.

investing.com • 04/10/2024 - 10:08 AM